![]() | |
![]() | |
Clinical data | |
---|---|
Trade names | Dsuvia, Sufenta, Zalviso, others |
Other names | R30730 |
AHFS/ Drugs.com | Monograph |
License data |
|
Routes of administration | Intravenous therapy (IV), intramuscular injection (IM), subcutaneous injection (SQ), epidural, intrathecal |
Drug class | Opioid |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 162 minutes |
Duration of action | Up to 4 hr [1] |
Identifiers | |
| |
Chemical and physical data | |
Formula | C22H30N2O2S |
Molar mass | 386.55 g·mol−1 |
3D model ( JSmol) | |
Melting point | 97 °C (207 °F) |
| |
| |
(verify) |
Sufentanil, sold under the brand names Sufenta among others, is an opioid medication used to treat moderate to severe pain and during anesthesia. [1] [2] It may be given under the tongue, by injection into a vein, or into epidural space. [1] [2] Effects last for up to 4 hours. [1]
Common side effects include respiratory depression (insufficient breathing) and stiff muscles. [1] Other side effects may include abuse, adrenal insufficiency, low blood pressure, androgen deficiency, and serotonin syndrome. [1] It works by attaching to μ-opioid receptors in the brain. [2]
Sufentanil was first made in 174 and approved for medical use in the United States in 1984. [3] [1] In the United States it costs about 50 USD for 500 ucg as of 2021. [4] In the United States it is classified as a Schedule II controlled substance. [1]
![]() | |
![]() | |
Clinical data | |
---|---|
Trade names | Dsuvia, Sufenta, Zalviso, others |
Other names | R30730 |
AHFS/ Drugs.com | Monograph |
License data |
|
Routes of administration | Intravenous therapy (IV), intramuscular injection (IM), subcutaneous injection (SQ), epidural, intrathecal |
Drug class | Opioid |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 162 minutes |
Duration of action | Up to 4 hr [1] |
Identifiers | |
| |
Chemical and physical data | |
Formula | C22H30N2O2S |
Molar mass | 386.55 g·mol−1 |
3D model ( JSmol) | |
Melting point | 97 °C (207 °F) |
| |
| |
(verify) |
Sufentanil, sold under the brand names Sufenta among others, is an opioid medication used to treat moderate to severe pain and during anesthesia. [1] [2] It may be given under the tongue, by injection into a vein, or into epidural space. [1] [2] Effects last for up to 4 hours. [1]
Common side effects include respiratory depression (insufficient breathing) and stiff muscles. [1] Other side effects may include abuse, adrenal insufficiency, low blood pressure, androgen deficiency, and serotonin syndrome. [1] It works by attaching to μ-opioid receptors in the brain. [2]
Sufentanil was first made in 174 and approved for medical use in the United States in 1984. [3] [1] In the United States it costs about 50 USD for 500 ucg as of 2021. [4] In the United States it is classified as a Schedule II controlled substance. [1]